M. El Badry

Renal resistive index in non-alcoholic fatty liver disease as an indicator of early renal affection

A. Hussein, H. El-Hariri, H. Mahmoud, 2020, Egyptian Liver Journal.

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes

I. Kabbash, G. Esmat, W. Doss, 2018, American journal of therapeutics.

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control

Noha Eltaweel, M. El Badry, D. Ali, 2020, Egyptian Liver Journal.

MYOSTATIN LEVEL IN CRF PATIENTS WITH AND WITHOUT POST-HCV CIRRHOSIS AND ITS CORRELATION WITH BMI

M. El Badry, M. Makhlouf, M. Salama, 2020 .

Management of liver disease patients in different clinical situations during COVID-19 pandemic

G. Shiha, S. Zaky, S. Abd-Elsalam, 2021, Egyptian Liver Journal.

Egyptian liver library: An indexed database for liver disease evidence in Egypt.

M. Alboraie, S. Ezzat, N. Youssef, 2019, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study.

W. Doss, S. Zaky, F. El-Raey, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Real-world results of direct-acting antivirals use for the treatment of chronic hepatitis C in old patients

M. Alboraie, S. Ezzat, N. Youssef, 2019, European Geriatric Medicine.